OrSense

OrSense

Pre-clinical
San Francisco, United StatesFounded 2004orsense.com

The NBM 200 is a non‐invasive blood analytes monitor. It measures and displays blood Hemoglobin (Hb), Oxygen saturation level* and Pulse Rate (PR) values.

Founded
2004
Focus
Medical DevicesDiagnostics

About

The NBM 200 is a non‐invasive blood analytes monitor. It measures and displays blood Hemoglobin (Hb), Oxygen saturation level* and Pulse Rate (PR) values.

Funding History

2

Total raised: $13.8M

Series A$12MUndisclosedSep 15, 2022
Seed$1.8MUndisclosedMay 15, 2019

Company Info

TypePrivate
Founded2004
LocationSan Francisco, United States
StagePre-clinical
SIMILAR COMPANIES
BASi Research Products
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
EydisBio
Pre-clinical · Cambridge
3Spine
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile